Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction
N. Engl. J. Med 2019 Sep 19;[EPub Ahead of Print], JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, FA Martinez, P Ponikowski, MS Sabatine, IS Anand, J Bělohlávek, M Böhm, CE Chiang, VK Chopra, RA de Boer, AS Desai, M Diez, J Drozdz, A Dukát, J Ge, JG Howlett, T Katova, M Kitakaze, CEA Ljungman, B Merkely, JC Nicolau, E O'Meara, MC Petrie, PN Vinh, M Schou, S Tereshchenko, S Verma, C Held, DL DeMets, KF Docherty, PS Jhund, O Bengtsson, M Sjöstrand, AM LangkildeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.